Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.9588
Abstract: Key Points Question Can widely available atrophy measures on magnetic resonance imaging (MRI) increase diagnostic accuracy of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD)? Findings In this diagnostic study of 326 participants, different methods… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51065
Abstract: MDS‐criteria for clinical diagnosis of progressive supranuclear palsy (PSP) were recently published, their usability in a classical clinical setting is yet unknown. We retrospectively applied the new criteria using PSP patients’ case files. Assignment of… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Annals of Neurology"
DOI: 10.1002/ana.26455
Abstract: To identify the clinical characteristics of the subgroup of benign progressive supranuclear palsy with particularly long disease duration; to define neuropathological determinants underlying variability in disease duration in progressive supranuclear palsy. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Brain and Behavior"
DOI: 10.1002/brb3.2547
Abstract: Progressive supranuclear palsy (PSP) is a progressive neurodegenerative condition presenting with different clinical endophenotypes. The parkinsonian variant of PSP (PSP‐P) is characterised by early but fading responsiveness to high‐dose levodopa therapy; however, high‐dose oral therapy… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Brain and Behavior"
DOI: 10.1002/brb3.2827
Abstract: Both progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) belong to atypical parkinsonian syndromes. It is important to differentiate these diseases accurately. We compared clinical outcomes and cognitive impairments between PSP and MSA. read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Brain and Behavior"
DOI: 10.1002/brb3.3527
Abstract: Sequential working memory is the ability to maintain and manipulate sequential information at a second time scale. Patients with progressive supranuclear palsy (PSP) or Parkinson's disease (PD) perform poorly in tests that require the flexible… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Brain and Behavior"
DOI: 10.1002/brb3.3552
Abstract: Hepcidin is a peptide associated with controlling the distribution of iron in tissues. Growing interest is linked with its impact on neurodegenerative diseases, as disruption of the iron regulation may be considered an initiatory element… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Brain and Behavior"
DOI: 10.1002/brb3.616
Abstract: OBJECTIVES To clarify whether weight change in patients with Parkinson's disease (PD) or progressive supranuclear palsy (PSP) is caused by the disease itself or secondarily by other factors. MATERIALS AND METHODS We conducted a retrospective… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.12491
Abstract: Slowed and curved rapid eye movements, saccades, are the well‐known features of progressive supranuclear palsy (PSP). The authors hypothesized that the saccades in PSP not only are slow and curved but also are irregular and… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.13455
Abstract: Contrary to pure cases, the influence of comorbid argyrophilic grain disease (AGD) in progressive supranuclear palsy (PSP) has not been sufficiently evaluated. read more here.